Number of the records: 1
n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet
- 1.
SYSNO ASEP 0335665 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet Title n-3 mastné kyseliny a roziglitazon zlepšují citlivost k inzulínu přes pomocný stimulační efekt na syntézu glykogenu ve svalu u myší krmených vysokotukovou dietou Author(s) Kuda, Ondřej (FGU-C) RID, ORCID, SAI
Jeleník, Tomáš (FGU-C)
Jílková, Zuzana (FGU-C)
Flachs, Pavel (FGU-C) RID
Rossmeisl, Martin (FGU-C) RID, ORCID
Hensler, Michal (FGU-C)
Kazdová, L. (CZ)
Ogston, N. (GB)
Baranowski, M. (PL)
Gorski, J. (PL)
Janovská, Petra (FGU-C) RID, ORCID
Kůs, Vladimír (FGU-C)
Polák, J. (CR)
Mohamed-Ali, V. (GB)
Burcelin, R. (FR)
Cinti, S. (IT)
Bryhn, M. (NO)
Kopecký, Jan (FGU-C) RID, ORCIDSource Title Diabetologia - ISSN 0012-186X
Roč. 52, č. 5 (2009), s. 941-951Number of pages 11 s. Language eng - English Country DE - Germany Keywords fish oil ; rosiglitazone ; obesity Subject RIV FB - Endocrinology, Diabetology, Metabolism, Nutrition R&D Projects GA303/08/0664 GA ČR - Czech Science Foundation (CSF) 1M0520 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) OC08007 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) CEZ AV0Z50110509 - FGU-C (2005-2011) UT WOS 000264884100027 DOI 10.1007/s00125-009-1305-z Annotation DHA/EPA and rosiglitazone exerted additive effects in prevention of obesity, adipocyte hypertrophy, low–grade adipose tissue inflammation, dyslipidaemia and insulin resistance, while inducing adiponectin, suppressing hepatic lipogenesis and decreasing muscle ceramide concentration in mice fed high-fat diet. The improvement in glucose tolerance reflected a synergistic stimulatory effect of the combined treatment on muscle glycogen synthesis and its sensitivity to insulin. The combination treatment also reversed dietary obesity, dislipedemia and IGT Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2010
Number of the records: 1